GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » cbdMD Inc (AMEX:YCBD) » Definitions » Debt-to-Equity

cbdMD (YCBD) Debt-to-Equity : 1.72 (As of Mar. 2025)


View and export this data going back to 2017. Start your Free Trial

What is cbdMD Debt-to-Equity?

cbdMD's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2025 was $0.75 Mil. cbdMD's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2025 was $0.40 Mil. cbdMD's Total Stockholders Equity for the quarter that ended in Mar. 2025 was $0.67 Mil. cbdMD's debt to equity for the quarter that ended in Mar. 2025 was 1.72.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for cbdMD's Debt-to-Equity or its related term are showing as below:

YCBD' s Debt-to-Equity Range Over the Past 10 Years
Min: -0.05   Med: 0.11   Max: 2.2
Current: 1.72

During the past 10 years, the highest Debt-to-Equity Ratio of cbdMD was 2.20. The lowest was -0.05. And the median was 0.11.

YCBD's Debt-to-Equity is ranked worse than
93.49% of 814 companies
in the Drug Manufacturers industry
Industry Median: 0.26 vs YCBD: 1.72

cbdMD Debt-to-Equity Historical Data

The historical data trend for cbdMD's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

cbdMD Debt-to-Equity Chart

cbdMD Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.11 0.06 0.16 0.41 0.65

cbdMD Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.86 1.36 0.65 0.91 1.72

Competitive Comparison of cbdMD's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, cbdMD's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


cbdMD's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, cbdMD's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where cbdMD's Debt-to-Equity falls into.


;
;

cbdMD Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

cbdMD's Debt to Equity Ratio for the fiscal year that ended in Sep. 2024 is calculated as

cbdMD's Debt to Equity Ratio for the quarter that ended in Mar. 2025 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


cbdMD  (AMEX:YCBD) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


cbdMD Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of cbdMD's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


cbdMD Business Description

Traded in Other Exchanges
N/A
Address
2101 Westinghouse Boulevard, Suite A, Charlotte, NC, USA, 28273
cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD as well as ATRx Labs brand of functional mushrooms. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.
Executives
Thomas Ronan Kennedy officer: Interim CEO and CFO 8845 RED OAK BLVD, CHARLOTTE NC 28217
Bakari T. Sellers director 4231 VOORHEES ROAD, DENMARK SC 29042
Raines William F Iii director 8314 TOSOMOCK LANE, HUNTERSVILLE NC 28078
Scott G. Stephen director 4249 NORTH WINCHESTER AVE., CHICAGO IL 60613
Sibyl Nichole Swift director 730 HAWTHORNE LANE, APT 441, CHARLOTTE NC 28204
Kevin Macdermott officer: President 9580 CALDWELL RD, MOUNT ULLA NC 28125
Wiesehan John J Iii officer: Chief Revenue Officer 8845 RED OAK BOULEVARD, CHARLOTTE NC 28217
Sim Farar director 8845 RED OAK BOULEVARD, CHARLOTTE NC 28217
Martin A. Sumichrast director, officer: Chairman of the Board and CEO 11125 COLONIAL COUNTRY LANE, CHARLOTTE NC 28277
Raymond Scott Coffman director 230 S. TRYON ST., #1302, CHARLOTTE NC 28202
Peter J. Ghiloni director 115 DEER ESTATES LANE, PONTE VEDRA BEACH FL 32082
Mark S Elliott officer: CFO & COO C/O LEVEL BRANDS, INC., 4521 SHARON ROAD, SUITE 450, CHARLOTTE NC 28211
Gregory C Morris director 421 CRANBORNE CHASE, FORT MILL SC 29708
Caryn Nicole Dunayer officer: President 8476 CATAWBA DOVE DR., BELMONT NC 28012
Erik Sterling 10 percent owner 5505 KALANIANAOLE HWY, HONOLULU HI 96821

cbdMD Headlines

From GuruFocus

Q1 2025 cbdMD Inc Earnings Call Transcript

By GuruFocus News 02-14-2025

Q4 2021 cbdMD Inc Earnings Call Transcript

By GuruFocus Research 02-15-2024

Q2 2022 cbdMD Inc Earnings Call Transcript

By GuruFocus Research 02-15-2024

Q4 2023 cbdMD Inc Earnings Call Transcript

By GuruFocus Research 02-15-2024

Q3 2021 cbdMD Inc Earnings Call Transcript

By GuruFocus Research 02-15-2024

Q3 2022 cbdMD Inc Earnings Call Transcript

By GuruFocus Research 02-15-2024

Q1 2023 cbdMD Inc Earnings Call Transcript

By GuruFocus Research 02-15-2024

Q4 2024 cbdMD Inc Earnings Call Transcript

By GuruFocus News 12-27-2024